Abstract
6/2011
vol. 10
Original paper
Diagnostic and prognostic value of O-linked N-acetylglucosamine transferase transferase in bladder neoplastic transformation in postmenopausal women
Przegląd Menopauzalny 2011; 6: 432–435
Online publish date: 2011/12/28
Aim of the study : The aim of the study was to evaluate the usefulness of mRNA expression of O-GlcNAc transferase (OGT) for bladder neoplasm diagnosis and disease prognosis in postmenopausal women.
Material and methods : OGT expression was measured by a real-time PCR assay in urine obtained from
52 postmenopausal women with bladder neoplasms and 37 healthy women. For the studied gene, cut-off, specificity and sensitivity were estimated.
Results: For OGT, the cut-off value was 416.93, sensitivity 100% and specificity 88.9%. Expression of OGT was established in 36/46 (78.2%) urine specimens taken from women with bladder cancer and in 18/37 (48.6%) urine specimens from healthy women. There was no OGT expression in women with papillary urothelial neoplasms of low malignant potential (PUNLMP).
Conclusions : Measurement of OGT mRNA level in urine samples obtained from postmenopausal women with urinary bladder cancer may be a useful marker of diagnosis and prognosis.
Material and methods : OGT expression was measured by a real-time PCR assay in urine obtained from
52 postmenopausal women with bladder neoplasms and 37 healthy women. For the studied gene, cut-off, specificity and sensitivity were estimated.
Results: For OGT, the cut-off value was 416.93, sensitivity 100% and specificity 88.9%. Expression of OGT was established in 36/46 (78.2%) urine specimens taken from women with bladder cancer and in 18/37 (48.6%) urine specimens from healthy women. There was no OGT expression in women with papillary urothelial neoplasms of low malignant potential (PUNLMP).
Conclusions : Measurement of OGT mRNA level in urine samples obtained from postmenopausal women with urinary bladder cancer may be a useful marker of diagnosis and prognosis.
Keywords
molecular marker, O-GlcNAc transferase, OGT, bladder cancer in women
Coverage in
Indexed in
Integrated with
Editorial Policies
